One of the psoriasis and psoriatic arthritis drugs currently in clinical trials (ustekinumab) seems to be doing well - here's the article.
I'm still waiting for the drug that is helping 90% of people who try it, however. The fact that these drugs only help 60% reinforces my belief that this disease is a tricky one, and there is more than meets the eye in understanding all the underlying processes involved.
BTW - according to Wikipedia, Ustekinumab targets IL-12 and IL-23 - some of our genes to watch out for.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment